Genome Therapeutics Ltd
ActiveData to 4 Nov 2026, 02:03
- Company number
- 12392992
- Sector
- Not in a live sector
- SIC group
- Life sciences and health
- Region
- London (London)
- Incorporated
- 8 Jan 2020
- SIC code
- 72110
- Trading name
- Not found
- Website
- Not found
Genome Therapeutics Ltd has 3 priced rounds on record from share allotment filings at Companies House. The latest was allotted on 26 Nov 2025, raised $10.5m USD, and was filed on 11 Dec 2025. Data to 3 Nov 2026.
3
Priced rounds
Allotted Oct 2024 to Nov 2025
£766k
Cash raised in those rounds
Sum of sterling cash raised in each round, as filed
26 Nov 2025
Latest round allotted
Filed 11 Dec 2025
Jump to
Funding rounds
Priced equity rounds read from share allotment filings at Companies House, newest first.
| Allotted | First filed | Cash raised | Filing |
|---|---|---|---|
| 26 Nov 2025Latest | 11 Dec 2025 | $10.5m USD | Open filing |
| 8 Aug 2025 | 7 Sep 2025 | $10.6m USD | Open filing |
| 18 Oct 2024 | 30 Oct 2024 | £766k | Open filing |
Companies with significant control
Companies with significant control over Genome Therapeutics Ltd, from the register of people with significant control. A company can have control without holding shares. Individuals are not shown on public pages.
No corporate holder of 25% or more is registered.
From the PSC register.
Filings
The latest 6 capital filings other than share allotments (SH01), which are listed under Funding rounds. 16 share filings (SH01, SH02, SH03, SH06 and SH08) have been read for this company.
| Date | Filing | Document |
|---|---|---|
| 18 Dec 2025 | Resolution | Open at Companies House |
| 18 Dec 2025 | Memorandum and articles (MA) | Open at Companies House |
| 28 Oct 2025 | Resolution | Open at Companies House |
| 2 Sep 2025 | Change of share class name (SH08) | Open at Companies House |
| 26 Aug 2025 | Resolution | Open at Companies House |
| 22 Aug 2025 | Memorandum and articles (MA) | Open at Companies House |
Documents open at Companies House. Bradshaw does not store or re-host them.
About this page
This page shows public register data for Genome Therapeutics Ltd. Figures come from filings at Companies House; Bradshaw links to each filing and does not host copies. To correct or object to data about you, use the data request form.
Last updated 3 Nov 2026